Mirati Therapeutics, Inc.
MRTX
Revenue
16.40M
▲2.71M▲19.80%
3 Months ChangeAssets
1.13B
▲214.67M▲23.46%
3 Months ChangeLiabilities
183.24M
▼-2.85M▼-1.53%
3 Months ChangeFree Cash Flow
-190.45M
▼-28.84M▼-17.85%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-01-23
Form 8-K
ID: 0001140361-24-003287
2023-12-19
Form 8-K
ID: 0001140361-23-058292
2023-12-13
Form 8-K
ID: 0001140361-23-057484
2023-11-24
Form 8-K
ID: 0001140361-23-054593
2023-11-13
Form 8-K
ID: 0001628280-23-038596
2023-11-06
Form 8-K
ID: 0001628280-23-036894
2023-11-06
Form 10-Q
ID: 0001628280-23-036875
2023-10-10
Form 8-K
ID: 0001193125-23-253090
2023-08-23
Form 8-K
ID: 0001628280-23-030373
2023-08-09
Form 8-K
ID: 0001193125-23-207441